Evolution and prognosis of patients with Asthma or COPD hospitalized by COVID-19 infection. Diferences between them and the patients without airway pathology.
B. Urrutia Royo (Badalona, Spain), C. Martinez Rivera (Badalona, Spain), T. Zapata (Badalona, Spain), I. Garcia Olivé (Badalona, Spain), K. Portillo (Badalona, Spain), A. Marín Tapia (Badalona, Spain), J. Abad Capa (Badalona, Spain), A. Rosell Gratacós (Badalona, Spain)
Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Urrutia Royo (Badalona, Spain), C. Martinez Rivera (Badalona, Spain), T. Zapata (Badalona, Spain), I. Garcia Olivé (Badalona, Spain), K. Portillo (Badalona, Spain), A. Marín Tapia (Badalona, Spain), J. Abad Capa (Badalona, Spain), A. Rosell Gratacós (Badalona, Spain). Evolution and prognosis of patients with Asthma or COPD hospitalized by COVID-19 infection. Diferences between them and the patients without airway pathology.. 966
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: